O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-15.63%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.36B
AUM Growth
+$5.36B
(-35%)
Cap. Flow
-$1.44B
Cap. Flow
% of AUM
-26.93%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
161
New
13
Increased
16
Reduced
46
Closed
30
Top Buys
| 1 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$92.4M |
| 2 |
LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
|
$67.3M |
| 3 |
Guardant Health
GH
|
$57.7M |
| 4 |
CVS Health
CVS
|
$52M |
| 5 |
CELG
Celgene Corp
CELG
|
$50.8M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$149M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$81.2M |
| 3 |
Edwards Lifesciences
EW
|
$80.4M |
| 4 |
Merck
MRK
|
$80.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
$79M |
Sector Composition
| 1 | Healthcare | 96% |
| 2 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCDA
1
DELISTED
Tricida, Inc. Common Stock
TCDA
| $257M | 4.75% | 10,889,280 | – | – |
|
2
Ascendis Pharma
ASND
$11.8B
| $256M | 4.74% | 4,087,373 -68,518 | -2% | -$4.29M |
|
3
Biogen
BIIB
$19.4B
| $251M | 4.65% | 835,249 -75,051 | -8% | -$22.6M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $209M | 3.86% | 3,256,700 +792,850 | +32% | +$50.8M |
|
5
Boston Scientific
BSX
$156B
| $205M | 3.78% | 5,790,400 -2,073,595 | -26% | -$73.3M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $199M | 3.69% | 2,047,400 -833,703 | -29% | -$81.2M |
|
|
7
Merck
MRK
$210B
| $191M | 3.53% | 2,495,000 -1,049,400 | -30% | -$80.2M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $188M | 3.47% | 1,133,200 -467,300 | -29% | -$77.4M |
|
|
WMGI
9
DELISTED
Wright Medical Group Inc
WMGI
| $134M | 2.47% | 4,905,899 -1,533,669 | -24% | -$41.7M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $128M | 2.37% | 957,000 -193,405 | -17% | -$25.9M |
|
|
CMTA
11
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $123M | 2.27% | 10,425,225 | – | – |
|
12
Viatris
VTRS
$12.3B
| $109M | 2.02% | 3,986,200 -793,400 | -17% | -$21.7M |
|
13
Thermo Fisher Scientific
TMO
$186B
| $97.9M | 1.81% | 437,500 -230,500 | -35% | -$51.6M |
|
|
THOR
14
DELISTED
Synthorx, Inc. Common Stock
THOR
| $92.4M | 1.71% | +5,316,355 | New | +$92.4M |
|
15
Cigna
CI
$80.3B
| $91.7M | 1.7% | 482,700 -151,200 | -24% | -$28.7M |
|
16
Sarepta Therapeutics
SRPT
$1.78B
| $85.2M | 1.58% | 781,000 -73,400 | -9% | -$8.01M |
|
17
Regeneron Pharmaceuticals
REGN
$61.5B
| $83M | 1.53% | 222,100 -172,300 | -44% | -$64.4M |
|
18
Intuitive Surgical
ISRG
$170B
| $81.7M | 1.51% | 170,500 +78,300 | +85% | +$37.5M |
|
19
Elevance Health
ELV
$71.8B
| $80.2M | 1.48% | 305,400 -168,600 | -36% | -$44.3M |
|
20
Inspire Medical Systems
INSP
$2.77B
| $77.3M | 1.43% | 1,829,449 -614,772 | -25% | -$26M |
|
21
Illumina
ILMN
$15.8B
| $73.8M | 1.36% | 245,900 -21,600 | -8% | -$6.48M |
|
|
PRNB
22
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $71.4M | 1.32% | 2,605,713 | – | – |
|
|
23
Edwards Lifesciences
EW
$47.8B
| $71.3M | 1.32% | 465,600 -525,000 | -53% | -$80.4M |
|
|
IMMU
24
DELISTED
Immunomedics Inc
IMMU
| $70.9M | 1.31% | 4,967,403 +638,830 | +15% | +$9.12M |
|
|
LOGC
25
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $67.3M | 1.24% | +6,466,783 | New | +$67.3M |
|